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Abstract
The present day lifestyle heavily depends on industrial chemicals in the form of agriculture, cosmetics, textiles and medical
products. Since the toxicity of the industrial chemicals has been a concern to human health, the need for alternative non-
toxic natural products or adjuvants that serve as antidotes are in high demand. We have investigated the effects of
Ayurvedic herb Ashwagandha (Withania somnifera) leaf extract on methoxyacetic acid (MAA) induced toxicity. MAA is a
major metabolite of ester phthalates that are commonly used in industry as gelling, viscosity and stabilizer reagents. We
report that the MAA cause premature senescence of normal human cells by mechanisms that involve ROS generation, DNA
and mitochondrial damage. Withanone protects cells from MAA-induced toxicity by suppressing the ROS levels, DNA and
mitochondrial damage, and induction of cell defense signaling pathways including Nrf2 and proteasomal degradation.
These findings warrant further basic and clinical studies that may promote the use of withanone as a health adjuvant in a
variety of consumer products where the toxicity has been a concern because of the use of ester phthalates.
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Introduction
Methoxyacetic acid (MAA, CH3OCH2COOH) is a primary
metabolite of ester phthalates, a class of industrial chemicals used
in a large variety of consumer products including household
products (building materials, plastic objects, textiles, adhesives,
paints and deodorants), food and personal care products
including agricultural adjuvant, pesticides, cosmetics and per-
fumes, electronics (coatings, stabilizers and surfactants) and
pharmaceuticals (enteric coating of oral pills, viscosity control
agents, surfactants and stabilizers). The most widely-used
phthalates are the di-2-ethyl hexyl phthalate (DEHP)- a low cost
plasticizer used in PVC, benzylbutylphthalate (BBzP)- used in the
manufacture of foamed PVC used as a flooring material, the
diisodecyl phthalate (DIDP)-viscosity controlling reagent, the
diisononyl phthalate (DINP) and small phthalates-used as solvents
in perfumes and pesticides. Globally, more than 18 billion pounds
of ester phthalates are used annually and toxicity of these
chemicals occurs through ingestion, inhalation, intravenous
injection and dermal exposure on a daily basis. In the United
States and Canada, DEHP is no longer used to manufacture
children’s products intended for mouthing, such as pacifiers, but
it is still used in larger toys. DEHP is approved for use in medical
devices such as surgical vinyl gloves, blood bags, tubes and
dialysis equipments. Dibutyl phthalate (DBP) is widely used in
many cosmetic products including perfume, lotion, and nail
polish putting women to a higher health-hazard risk category.
Ester phthalates family, monoethyl phthalate (MEP), monobutyl
phthalate (MBP), monobenzyl phthalate (MBzP), and mono(2-
ethylhexyl) phthalate (MEHP) have been detected in urine
specimens, and their diester parent compounds in house dust
samples, from pregnant and lactating women living in New York
City [1]. Breast milk has been reported to contain phthalate
metabolite monoesters in samples from Denmark/Finland [2],
Sweden [3] and Italy [4].
Laboratory studies have shown that the toxicity of ester
phthalates is caused by their metabolite, MAA. Gavage and
intraperitoneal (i. p.) administration of MAA in rats resulted in
their physical, reproductive, skeletal and hematopoietic abnor-
malities [5,6] and it was shown to be a proximal teratogenic
metabolite of 2-methoxyethanol (ME) and 2-Dimethoxyethyl
phthalate (DMEP) [5,7]. The toxicity of MAA has been shown to
be mediated by multiple signaling pathways including oxidative
stress, apoptosis, upregulation of heat shock proteins and
deregulation of kinases, inhibition of histone deacetylase and
disruption of estrogen receptor-mediated signaling [7–18]. In
view of the extensive industrialization of present day lifestyle,
there is a substantial urgency for molecular investigation to
resolve the mechanism(s) of MAA toxicity and to invent novel
ways and reagents to overcome its deleterious effects on human
health.
In the present study, we report that a phytochemical,
withanone, extracted from leaves of Ashwagandha protects human
normal cells against the toxicity of MAA. We provide the very first
molecular evidence showing the anti-toxic effects of withanone in
normal human cells and propose its use as a MAA-antidote.
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MAA causes senescence like growth arrest of normal
human fibroblasts
Normal human fibroblasts were cultured in the control
medium for 24 h. Cells were then treated either with withanone-
or MAA-supplemented medium for 48 h followed by recovery
by placing them in either control normal medium or withanone-
supplemented medium, respectively, for the next 24–48 h. As
shown in Figure 1A, the treatment with MAA led to decrease in
relative density of cells as detected by crystal violet DNA
staining. Cell viability analysis by Alamar BlueH-cell proliferation
assay revealed less number of viable cells in MAA-treated
cultures. Cells cultured in the presence of withanone recovered
from MAA-induced growth arrest and decline in viability. Of
note, withanone treatment either before (Figure 1B–E) or after
(Figure 1B–F) the exposure to MAA was effective in recovering
the cells from MAA-induced cyto-toxicity. We next performed
senescence-associated b-galactosidase staining assay in control
and MAA-treated cells. Whereas MAA caused significant
increase in senescence-associated b-galactosidase staining, the
number of cells showing senescence like growth arrest
(Figures 1C and 1D) declined in the presence of withanone
suggesting that the MAA-induced cellular damage caused
premature senescence in normal fibroblasts, and withanone
protected the cells from such deteriorative phenotype. In order
to get further insights to the kind of growth arrest induced by
MAA, we performed cell cycle analysis on the control and
treated cells. As shown in Figure 1E, MAA-treated cultures
showed significant increase in number of cells in G1 stage of the
cell cycle and decrease in number of cells in S phase. Subsequent
recovery of MAA-treated cells in withanone-supplemented
culture medium reinitiated the cell cycle progression and entry
into S phase (Figure 1E).
Molecular pathways involved in MAA-induced premature
senescence in normal human fibroblasts
In order to understand the molecular mechanism of MAA-
induced growth arrest of normal human fibroblasts, we
hypothesized that MAA may induce ROS resulting in oxidative
damage to DNA and mitochondria, and that in turn induce DNA
damage signaling and loss of mitochondrial membrane potential
culminating in growth arrest of cells by pathways shown in
Figure 2A. In order to test this hypothesis, we examined whether
MAA caused ROS generation in cells. As shown in Figure 2B,
cells treated with MAA for 6 and 12 h showed ROS generation,
the amount of which was doubled in cells treated with 10 mM
MAA for 12 h (Figure 2C). Furthermore, we found that while the
cells treated with MAA showed ROS induction, the recovery
treatment with withanone caused significant reduction in ROS
indicating the involvement of ROS pathway in the process
(Figures 2D and 2A).
Involvement of ROS and DNA damage response in
MAA-induced premature senescence of normal human
fibroblasts and its recovery by withanone
We next examined the above hypothesis by undertaking the
expression analysis of molecules involved in ROS-induced DNA
damage signaling and growth arrest of cells. As shown in
Figure 3A, MAA caused an induction of DNA damage as
examined by cH2AX focus formation. Noticeably, recovery of
cells in withanone-supplemented medium resulted in the reduction
of cH2AX expression (Figures 3A and 3B). These data
demonstrated that the DNA damage caused by MAA was rectified
by the addition of withanone. We next analyzed p53 and p21
WAF1
(the two key molecular mediators of DNA damage response and
senescence pathway) expression in MAA-treated and withanone-
recovered cells. As shown in Figure 3C, p53 and p21 were induced
in MAA-treated cells in a dose-dependent manner. Furthermore,
MAA-treated and withanone-recovered cells showed considerable
normalization of both p53 and p21
WAF1 (Figures 3A and 3D).
These data demonstrated that the MAA-induced DNA damage
and growth arrest of normal cells were blocked by withanone.
We next examined p16
INK4A-RB pathway, another major
tumor suppressor pathway involved in senescence and has been
shown to be upregulated in response to accumulation of DNA
damage and replicative senescence of normal human fibroblasts.
As shown in Figures 4A and 4B, p16
INK4A was upregulated in
MAA-treated cells and its downstream effector RB (Figure 2A) was
unphosphorylated (Figure 4A) leading to growth arrest of cells.
These were consistent with the cell cycle, cell viability and p53-
p21
WAF-1 status data as described above. Of note, in contrast to
the decrease in phospho-RB (Figure 4A), total RB expression was
increased in MAA-treated cells (Figures 4A and 4B). Furthermore,
consistent with the recovery from growth arrest, MAA-treated and
withanone-recovered cells showed decrease in p16
INK4A (p16),
recovery of phospho-RB and decrease in total RB (Figures 4A and
4B). These data revealed that the MAA-induced toxicity to normal
cells involve p16
INK4A-RB pathway and the treatment with
withanone leads to their recovery as hypothesized in our model
(Figure 2A).
Involvement of ROS and mitochondrial damage during
MAA-induced premature senescence of normal human
fibroblasts and its recovery by withanone
We next examined whether the ROS generated by MAA cause
mitochondrial damage by analyzing mitochondrial membrane
potential. We found that the cells when treated with MAA show
loss of membrane potential as indicated by loss of both JC1-red
and mitotracker staining. Most significantly, MAA-treated and
withanone-recovered cells exhibited recovery of both JC-1 red and
mitotracker staining suggesting that the mitochondrial membrane
potential of these cells was comparable to the normal untreated
cells (Figures 5A and 5B). Furthermore, to test whether the
treatment with withanone protected the normal cells against
Figure 1. MAA-induced premature senescence in normal human cells. A, Crystal violet staining of normal human (TIG-1) fibroblasts treated
with withanone (B), MAA (10 mM, 24 h)(C) and MAA followed by recovery in withanone-supplemented medium (MAARwithanone) (D). The
difference between A & C and C & D were statistically significant (*P,0.05). B, Viability of cells treated with withanone (B), MAA (C), MAA followed by
recovery either in normal medium (D) or in withanone-supplemented medium (F). Cells were also treated with withanone before MAA treatment (E).
The difference between A & C, D & E and D & F were statistically significant (*P,0.05). C, Senescence-associated b-gal staining in TIG-1 cells treated
with withanone (B), MAA (C) and MAARwithanone (D) treated cells. MAA treated cells showed increase in b-gal positive cells. The number of b-gal
positive cells decreased when recovered in withanone-supplemented medium. Quantitation of b-gal positive cells from three independent
experiments is shown in D. The differences between A & C, D & E and D & F were statistically significant (*P,0.05). E, Cell cycle distribution of control
(A), withanone (B), MAA (C) and MAARwithanone (D) cells is shown. MAA led to arrest of cells in G1 cell cycle phase but was normalized when
transferred to withanone-supplemented medium.
doi:10.1371/journal.pone.0019552.g001
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damage by treating with H2O2. As shown in Figure 5C, cell
viability was significantly improved when H2O2-treated cells were
recovered in withanone-supplemented medium demonstrating
that whereas MAA caused ROS generation, DNA and mitochon-
drial damage, withanone protected the cells against such damage
by suppressing ROS generation as hypothesized in our model
(Figure 2A).
Protection against ROS and MAA-induced premature
senescence of normal human fibroblasts involve an
induction of Nrf2-ARE signaling
Keap1-Nrf2-ARE signaling plays a significant role in protecting
cells from endogenous and exogenous stresses. Under normal
conditions, the transcription factor Nrf2, a primary transcription
factor required for the induction of a battery of phase II
detoxification genes through activation of antioxidant response
element (ARE), interacts with the actin-anchored protein Keap1
and is largely localized in the cytoplasm resulting in the low basal
expression of Nrf2-regulated genes. However, upon recognition of
chemical signals imparted by oxidative and electrophilic molecules
that cause activation of MAP kinase signaling, Nrf2 is phosphor-
ylated, released from Keap1, escapes proteasomal degradation,
translocates to the nucleus, and transactivates the expression of
several antioxidant and cytoprotective genes that increase
resistance to oxidative stress and mitochondrial dysfunction
leading to enhance cell survival (Figure 2A) [19]. We first
examined Nrf2 in normal human fibroblasts treated with oxidative
stress (H2O2) and during recovery phase in withanone-supple-
mented medium. As expected, normal cells treated with cytotoxic
Figure 2. MAA-induced ROS generation in normal human cells. A, Schematic presentation of the pathways predicted to be involved in MAA-
induced growth arrest/senescence of normal cells and its recovery by the addition of withanone. B, MAA-induced ROS generation in normal human
cells as early as 6–12 h of treatment time. C, ROS level in cells treated with 10 mM MAA for 12 h was double compared to the control. Increase in ROS
generation with 5 mM and 10 mM MAA were statistically significant (*P,0.05). D, Cells treated with MAA but recovered in withanone-supplemented
medium showed reduction in ROS as compared to the control that were recovered in normal medium. The MAA-induced increase and withanone-
induced recovery in ROS generation were statistically significant (*P,0.05).
doi:10.1371/journal.pone.0019552.g002
Figure 3. MAA-induced DNA damage and elevated level of p53-p21 expression in normal human cells. A, TIG-1 cells treated with
withanone, MAA and MAARwithanone were immunostained for DNA damage and growth arrest marker proteins, cH2AX, p53 and p21. MAA-treated
cells showed increase in all the three proteins. MAARwithanone treated cells did not show increase in any of these three proteins. B, Western
blotting for cH2AX showing increase in MAA, but not in MAARwithanone treated cells. C, Western blotting for p53 and p21 in control and MAA
treated cells. D, Western blotting for p53 and p21 in control, MAA, withanone and MAARwithanone treated cells. Actin was used as a loading control.
doi:10.1371/journal.pone.0019552.g003
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However, the cells treated with withanone resulted in an induction
of Nrf2 at much higher level than by genistein, a known inducer of
Nrf2 pathway (Figures 6A and 6B). Whereas MAA-treated cells
showed suppression of Nrf2, the MAA-treatment followed by
addition of withanone showed recovery through induction of Nrf2.
As shown in Figure 6C, withanone-recovered cells showed nuclear
translocation of Nrf2, associated with expression of ARE-regulated
gene glutathione S-transferase (GST) (Figure 6D). There was a loss
of 25–30% in GST activity in MAA-treated cells; withanone-
recovered cells showed 15–20% GST recovery. We also examined
the proteasomal activity in MAA-treated and withanone added
recovered cells. Withanone caused recovery of the MAA-induced
decrease in the proteasomal activity (Figure 6E).
The present day life heavily depends on industrial products and
hence it is a major challenge to protect human health against the
toxic effects of industrial chemicals. Genetic and functional toxicity
of MAA, a major metabolite of ester phthalates, has been shown in
a variety of in vitro and in vivo model studies [9,16,20–23]. It has
been shown to cause change in gene expression pattern [8], cell
environment [22] and mitochondrial function [24]. We had
previously shown that Ashwagandha leaf extract (i-Extract) and
withanone, a major constituent in the leaf, cause selective killing of
cancer cells [25,26]. Normal human fibroblasts were benefited by
treatment with i-Extract; these showed increase in lifespan,
reduction in the molecular damage and protection against
oxidative stress [27,28]. At this end, we investigated whether
MAA-induced damage to normal human cells in culture could be
recovered by the treatment with withanone. As shown above, we
found that the MAA caused ROS-mediated DNA and mitochon-
drial damage to normal human cells. The cells showed significant
recovery from such damages when subsequently treated with
withanone (Figures 2, 3, 4, 5). Furthermore, withanone stimulated
the Nrf2 signaling resulting in the nuclear translocation of Nrf2
and an increase in GST activity (Figure 6D) suggesting the
increase in cellular defense mechanism to overcome the oxidative
stress. Proteasomal function was also increased in cells that were
treated with withanone (Figure 6E). Taken together, these data
suggested that the cells treated with withanone could be protected
against MAA-toxicity by multiple mechanisms including reduction
in the production of ROS, subsequent damage at DNA and
mitochondrial level, and induction of cellular defense machinery
including Nrf2 signaling and proteasomal degradation. As a result
of these molecular effects of withanone, human normal cells were
protected against MAA-induced toxicity indicated by growth
arrest and premature senescence (Figure 1). These data suggest
that withanone is a strong candidate for health adjuvant and could
be recruited in multiple industrial products including cosmetics,
toiletry, and medical products containing ester phthalates that are
toxic and threat to human health.
Materials and Methods
Cell culture, treatments and viability assay
Normal human fibroblasts (TIG-1) were obtained from the
Japanese Collection of Research Bio-resources (JCRB, Japan) and
grown at 37uC in a 5% CO2 incubator in low glucose Dulbecco’s
modified Eagle’s minimal (DMEM; Gibco BRL, Grand Island,
NY) essential medium supplemented with 10% fetal bovine serum.
Cells (at about 50% confluency) were treated with 10 mM
Methoxyacetic Acid (MAA) (WAKO Chemicals, Japan) for 24 h
followed by culture in a medium-containing withanone 10 mg/mL
for 24 h for recovery treatments. For pretreatment, withanone was
added to the culture medium 24 h before the addition of MAA
Figure 4. MAA-induced p16-RB expression in normal human cells. A, Cells treated with withanone, MAA and MAARwithanone were
immunstained for p16 and RB. MAA-treated cells showed increase in p16 and RB. The level of phospho-RB decreased in MAA-treated cells.
MAARwithanone treated cells did not show increase in either p16 or RB. Phospho-RB level was comparable to the control and withanone-treated
cells. B, Western blotting for p16 and RB in control, withanone, MAA and MAARwithanone treated TIG-1 cells. Actin was used as a loading control.
doi:10.1371/journal.pone.0019552.g004
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treatment for 24 h followed by recovery in normal culture
medium) and treated cells were analyzed as described below.
Cell viability was examined using Alamar BlueH-cell prolifera-
tion assay kit (Invitrogen) following manufacturer’s instructions.
Briefly, cells (3610
3 cells) were plated in 96-well plates. After 24 h
of incubation, cells were treated with MAA (10 mM, for 24 h)
followed by culture in a fresh DMEM medium-supplemented with
Withanone (10 mg/mL) for 24 h. Cells were then incubated with
Alamar Blue (10% in DMEM) for 1 h. Change in Alamar Blue
color from blue nonfluorescent to red fluorescent (proportional to
the living and metabolically active cells) was recorded at 450 nm
(absorbance is monitored at 570 nm and 600 nm) in a microplate
reader. Cell viability was also assayed by Crystal violet staining.
Control and treated cells were washed with PBS and fixed in 1%
paraformaldehyde (15 mins at room temperature). After washing
twice with PBS, the cells were incubated with Crystal violet dye
(0.5% in H2O) at room temperature overnight. Cells were washed
with H2O and plates were photographed with image scanner
(EPSON GT-9800F).
Immunostaining
Immunostaining for the indicated proteins was performed as
described earlier [25]. Cells were grown on glass coverslips placed
in 12-well culture dishes. At the end of treatment, cells were
washed with cold phosphate-buffered saline (PBS) and fixed with
a pre-chilled methanol/acetone (1/1, v/v) mixture for 5 min on
ice. Fixed cells were washed thrice with PBS, permeabilized with
0.2% Triton X-100 in PBS for 10 min, and blocked with 2%
bovine serum albumin (BSA) in PBS for 20 min. Cells were
stained with antibodies against p53 (DO-1, Santa Cruz Biotech),
p21
WAF-1 (C-19, Santa Cruz Biotech), p16
INK4A (Ab-F12, Santa
Cruz Biotech), RB (Ab 4H1, Cell Signaling Technology),
phosphor-Rb (Ser 780, Cell Signaling Technology), Nrf2 (H-
300, Santa Cruz Biotech), cH2AX (Biolegend) and b-tubulin
(Sigma). Immunostaining was visualized by secondary staining
with Alexa-594-conjugated goat anti-rabbit and Alexa 488-
conjugated goat anti-mouse (Molecular Probes, Eugene, OR)
antibodies. After washing with PBS-TX (0.1% Triton X-100 in
PBS thrice) and PBS (once), cells were overlaid with FA mounting
fluid (VMRD, Inc). The cells were examined under a microscope
(Axiovert 200M; Carl Zeiss, Thornwood, NY) attached to an
AxioCam MRm monochrome charge-coupled device camera
(Carl Zeiss). The images were processed with AxioVision software
(version 4.4; Carl Zeiss).
For cH2AX immunostaining, cells were permeabilized with
KCM solution (120 mM KCl, 20 mM NaCl, 10 mM Tris pH 7.5,
0.1% Triton) and blocked with solution containing 2% BSA, 0.2%
Gelatin, 150 mM NaCl, 0.1% Triton X-100, 20 mM Tris pH 7.5,
0.1% Sodium Azide in MilliQ water for 30 mins.
Figure 5. MAA-induced loss in mitochondrial membrane potential (MMP) in normal human cells. A, Cells treated with withanone, MAA
and MAARwithanone were immunostained for JC1 and mitotracker. MAA-treated cells showed loss of MMP (loss of red staining). MAARwithanone
treated cells showed mitochondrial membrane potential comparable to that of the control cells. B, Quantitation of cells showing red JC1 staining
indicative of high mitochondrial membrane potential. MAA treatment caused decrease in the number of cells with high MMP and the recovery in the
withanone-supplemented medium resulted in an increase in the number of cells with high MMP (*P,0.05). C, Cell viability analysis of the control,
H2O2 and H2O2Rwithanone treated cells showing the recovery of cells. Cell viability was increased (statistical significance, *P,0.05) when they were
recovered from the oxidative stress by incubation in the withanone-supplemented medium.
doi:10.1371/journal.pone.0019552.g005
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PLoS ONE | www.plosone.org 7 May 2011 | Volume 6 | Issue 5 | e19552Figure 6. MAA-induced Nrf2 pathway in normal human cells. A, Cells treated with either H2O2 or MAA showed reduction in Nrf2. Cells treated
with H2O2Rwithanone or MAARwithanone showed increase in Nrf2. B, Induction of Nrf2 by withanone was stronger than genistein, a known
inducer of Nrf2 pathway. C, Nuclear translocation of Nrf2 in withanone, H2O2Rwithanone or MAARwithanone cells was observed by
immunostaining with Nrf2 specific antibody. D, MAA treated cells showed loss in GST activity and its recovery was observed in MAARwithanone cells
(*P,0.05). E, Proteasomal activity was decreased in MAA treated cells but recovered in MAARwithanone cells (*P,0.05).
doi:10.1371/journal.pone.0019552.g006
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Expression level of indicated proteins was examined by Western
blotting. Control and treated cells were harvested by trypsin,
washed and lysed in buffer containing 1% Nonidet P-40 in TBS
(20 mM Tris, 150 mM NaCl, pH 7.4)-supplemented with 10 mg/
ml of a protease inhibitor mixture (Roche). The whole cell lysate
was centrifuged at 12,000 rpm for 10–20 min at 4uC and
supernatant (10–20 mg) was resolved on SDS-polyacrylamide gel
electrophoresis under reducing conditions. The gel was transferred
onto Immobilon-P membranes (Millipore) using a semi-dry
transfer apparatus (ATTO, Japan). Membranes were probed with
antibodies against p53 (DO-1, Santa Cruz Biotech), p21
WAF-1 (C-
19, Santa Cruz Biotech), p16
INK4A (AbF12, Santa Cruz Biotech),
Rb (Ab4H-1, Cell Singaling Technology), Nrf2 (H-300, Santa
Cruz Biotech), cH2AX (Biolegend) and actin (Chemicon). After
washing with TBS-T, the membrane was incubated with
horseradish peroxidase-conjugated secondary antibody for
30 min. The membrane was washed thrice in TBS-T and once
in TBS, then subjected to an enhanced chemiluminescence (ECL)-
mediated visualization (Amersham Biosciences) using Lumino
Image Analyzer equipped with charge-coupled device (CCD)
camera (LAS3000-mini, Fuji Film).
Cell cycle analysis
The cells (about 50% confluent) were treated with MAA for
24 h followed by incubation in either control medium or in
withanone-supplemented medium for another 24 h for recovery
and then harvested by trypsin. Cells pellets were washed with cold
PBS and fixed in 70% ethanol at 4uC for 12 h. The fixed cells
were centrifuged at 2000 rpm for 10 min, washed with cold PBS
twice and then re-suspended in 0.25 ml PBS. The cells suspensions
were treated with RNAse A (5 ml, 1 mg/ml at 37uC for 1 h) to
remove RNA followed by incubation with Propidium Iodide (PI,
10 ml, 1 mg/ml) for 30 min in dark. PI-stained cells were subjected
to cell cycle analysis using Coulter Epics XL
TM Flow Cytometer
(Beckman).
Senescence-associated b-galactosidase assay
Control and treated cells were subjected to senescence-
associated b-galactosidase (SA-b-gal) staining using the standard
protocol. In brief, cells were first treated with MAA and then
incubated in either control medium or in withanone-supplemented
medium for recovery. The cells were washed with PBS, fixed in
2% formaldehyde/0.2% glutaraldehyde in PBS for 10 min, and
washed again with PBS, followed by an overnight incubation in
staining solution (citric acid/phosphate buffer, pH 6.0, 5 mM
K3Fe(CN)6, 5 mM K4Fe(CN)6, 2 mM MgCl2, 150 mM NaCl,
supplemented with 1 mg/ml of 5-bromo-4-chloro-3-indolyl-b-D-
galactopyranoside (X-gal) at 37uC. Stained cells were examined
under the microscope and photodocumented with a NIKON
camera.
Proteasome activity assay
Control and treated cells were harvested with cell scraper and
assayed for proteasome activity using Proteasome Activity Assay
kit (Chemicon). The assay is based on the detection of the
fluorophore 7-Amino-4-methylcoumarin (AMC) after cleavage
from the labeled substrate LLVY-AMC. The free AMC
fluorescence was quantitated using a 380/460 nm filter set in a
fluorometer.
Glutathione-S-transferase assay
Control and treated cells were subjected for analysis using
Glutahione-S-transferase Assay Kit (Cayman Chemical Company)
following manufacturer’s instructions. The cells (3610
4) were
seeded in 100-mm plate and treated with MAA for 24 h followed
by recovery either in normal or withanone-supplemented medium
for 24 h. Cells were then washed with cold PBS, scraped and
centrifuged at 20006 g for 10 min at 4uC. Cell pellets were
sonicated in cold 1–2 ml of cold buffer (100 mM potassium
phosphate, pH 7.0, containing 2 mM EDTA), centrifuged at
10,0006 g for 15 min at 4uC. The supernatant was subjected to
assay. Reduced glutathione (GSH) content in supernatant was
measured colorimetrically at 340 nm using plate reader.
Detection of reactive oxygen species
The reactive oxygen species were detected by fluorescent
staining using the Image-iT
TM LIVE Green Reactive Oxygen
Species (ROS) Detection Kit (Molecular Probes Inc, USA). Cells
were grown on glass coverslips placed in 12-well plate and were
treated as described above. Cells were fixed and then stained for
ROS by procedure recommended by the manufacturers.
JC1 staining and mitochondrial damage
Control and treated cells were incubated in JC-1 (Molecular
probes) 10 mg/ml dye containing media at 37uC for 10 min. The
JC-1 labeled cells were detected by fluorescent microscopy. Cells
were also incubated with MitoTracker Deep Red (150 nM) for
30 min and examined under fluorescence microscope (Carl Zeiss).
Statistical analysis
Statistical significance of the data (viability, SA-ß-gal assay,
ROS generation, mitochondrial membrane potential, GST and
proteasomal activity) was calculated from three independent
experiments using One-way ANOVA and Baferroni’s test. The
values were considered significant for P,0.05.
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